Inhibition of TFF3 enhances sensitivity—and overcomes acquired resistance—to doxorubicin in estrogen receptor-positive mammary carcinoma
10.3390/cancers11101528
Saved in:
Main Authors: | Poh, H.M., Chiou, Y.S., Chong, Q.Y., Chen, R.-M., Rangappa, K.S., Ma, L., Zhu, T., Kumar, A.P., Pandey, V., Basappa, Lee, S.-C., Lobie, P.E. |
---|---|
其他作者: | MEDICINE |
格式: | Article |
出版: |
MDPI AG
2021
|
主題: | |
在線閱讀: | https://scholarbank.nus.edu.sg/handle/10635/209544 |
標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|
相似書籍
-
PHARMACOLOGICAL INHIBITION OF TFF3 ENHANCES SENSITIVITY-AND OVERCOMES ACQUIRED RESISTANCE-TO DOXORUBICIN IN ESTROGEN RECEPTOR-POSITIVE BREAST CANCER
由: POH HAN MING
出版: (2020) -
THE ONCOGENIC ROLE OF TREFOIL FACTOR 3 (TFF3) IN NON-SMALL CELL LUNG CANCER (NSCLC)
由: ZHANG MENGYI
出版: (2019) -
THE ROLE OF TREFOIL FACTOR 3 IN MAMMARY CARCINOMA ANGIOGENESIS
由: LAU WAI HOE
出版: (2015) -
The role of TFF3 in cytotoxic drug resistance of breast cancer
由: ZHANG WANQIU
出版: (2014) -
Prognostic significance of the expression of GFRα1, GFRα3 and Syndecan-3, Proteins binding ARTEMIN, In mammary carcinoma
由: Wu, Z.-S., et al.
出版: (2014)